Prof. Rajko Reljic
Principal Investigator
Organisation/Institute: St George's, University of London
Email: rreljic@sgul.ac.uk
Supervisor of ESR 10
Rajko Reljic is Professor of Immunology in the Institute for Infection and Immunity at St George’s University of London.
Dr Reljic’s work focuses on several vaccine delivery systems for tuberculosis, Buruli ulcer and Dengue, including nanoparticles, inactivated bacterial spores, liposomes and self-adjuvanting recombinant immune complexes. He is also focused on immunotherapy as an adjunct treatment for tuberculosis (TB), especially in drug-resistant disease, using monoclonal antibodies of the IgA isotype.
Dr Reljic is the Coordinator of the EMI-TB consortium, a European Union-funded TB vaccine initiative that involves 14 research groups from Europe and Africa. He is Co-Chair of the Bill and Melinda Gates Foundation sponsored CTVD initiative – Aerosol Delivery and Mucosal Vaccine Community. He is also the executive member of the management board of the MRC-funded network for difficult intracellular pathogens (VALIDATE Network) and the Acid Fast Club, UK.
Dr Reljic is editorial board member for peer-review journals such as Scientific Reports and Frontiers in Immunology, and an active reviewer for many journals and funding agencies.